Phenelzine supply halted, new minimum rates for pharmacy workers, APP2021 dates announced and more
This week we heard that the sponsor of Nardil (phenelzine sulfate) tablets has notified the TGA that they can no longer supply this medication in Australia.
There are no alternative brands of phenelzine on the Australian market, the TGA said, and supplies of the tablets are very limited.
Pharmacists have been told to advise patients taking phenelzine to see their doctor regarding their treatment as soon as possible.
The PBS has released the list of medicines that are to be included in the October 2020 cycle of price disclosure reductions.
Meanwhile the Pharmacy Programs Administrator (PPA) has provided the deadline for final clinical intervention claims.
PPA said that while claiming for the April-June 2020 quarter will proceed as normal, “all claims must be lodged within the two-week claiming period of 1 July to 14 July 2020 and there will be no ability to lodge any exceptional circumstance requests beyond 31 July 2020”.
Health Minister Greg Hunt announced a three-month extension to the temporary Continued Dispensing (Emergency Measures).
The TGA’s Medicine Shortages Working Party decided that pharmacies can now return children’s paracetamol liquid formulations to front-of-counter, as demand for these products has eased.
New minimum rates for pharmacy workers kicked in from 1 July, after the Fair Work Commission (FWC) determined to increase all minimum award rates of pay by 1.75%.
Pharmacy Guild national president George Tambassis confirmed that additional supplies of this year’s flu vaccine ordered by the Federal Government are now available through community pharmacies, which earlier this year experienced shortages.
The Guild also announced the dates for the APP2021 Conference this week.
And finally, we asked our readers what you think of the 7CPA: vote in our poll here.